top of page
MN.jpg

IN THE STATES

MINNESOTA

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Minnesota in 2022.

MN.png

Economic
Output

$20.2B

Direct Jobs Supported by the Industry

13,220

Total Jobs Supported

66,920

State Total Vendor Relationships

840

State Total Vendor Spending

$397,091,867

Clinical
Trials

653

Investments at Clinical Trial Sites

$218M

Clinical Trial Participants

13,942

Total Economic Impact of Clinical Trial Sites

$629.8M

bottom of page